Gilead Sciences invests $11B to expand pharmaceutical manufacturing and R&D facilities in the United States
Gilead Sciences has announced plans to expand its manufacturing and research capabilities across the United States. The company, which develops and produces medicines, is investing $11 billion into capital and operational projects, creating around 800 new direct jobs and supporting more than 2,200 indirect jobs by 2028.
The investment will support the construction of three new facilities and upgrades to three existing sites, focused on boosting U.S. manufacturing and research and development capacity. Of the total investment, $4 billion will be allocated to capital projects such as laboratories and equipment, $5 billion will fund technology, operations, and R&D activities, and $2 billion will support digital and advanced engineering efforts. These developments are part of Gilead’s broader plan to invest $32 billion in U.S. manufacturing and R&D through 2030, which is projected to generate $43 billion in value to the U.S. economy over five years.
Investing in American manufacturing in 2025
This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.
About the Author
Alexis GajewskiAlexis Gajewski
Senior Content Strategist
Alexis Gajewski is a manufacturing writer and editor with nearly 20 years of experience covering the people, practices, and technologies that keep industrial facilities running. For more than a decade, she served as Senior Content Strategist for Plant Services, creating content for plant managers, engineers, and maintenance professionals on a variety of industrial topics.
During her tenure, Alexis worked to develop the brand’s digital strategy and helped launch and produce Great Question: A Manufacturing Podcast. She also created The Lighter Side of Manufacturing, a weekly blog that explored the inventive and sometimes humorous side of the industry.
Alexis co-founded Influential Women in Manufacturing, a recognition program that honored 49 women in its first two years, earned an industry award for Best Product Launch, and received a proclamation from Illinois Governor JB Pritzker and a commendation from U.S. Senator Tammy Duckworth.
She also led newsroom operations and development at a large media company where she set editorial standards, developed training curriculum, and helped support AI adoption for more than 150 editors across 80+ brands spanning manufacturing, industrial processing, automation, and more.
Additionally, Alexis works as a freelance writer and editor, and her areas of interest include continuous improvement, the skilled workforce, and the role of emerging technology on the plant floor.
Connect with Alexis on LinkedIn